Tag Archives: BPMX

Top Warren Buffett Stocks For 2018

It was a good year for Warren Buffett, the ‘Oracle of Omaha,’ who saw Berkshire Hathaway’s stock rise 23.4% in 2016 and the firm’s book value per share grow by 10.7%. In characteristic form Buffett, worth $76.3 billion according to FORBES’ Real Time Rankings, used his annual shareholder letter to offer a review of Berkshire’s performance during the year, which included a major bet on Apple and airlines and the closing of its $37.2 billion acquisition of Precision Castparts.

Berkshire Hathaway generated $17.6 billion in operating earnings, or a 1% annualized increase, from businesses that span insurance, railroads, industrials, chemicals and home-building, to name a few. Its capital gains, mostly from realized investments, were $6.5 billion. Buffett’s annual letter offered an optimistic view on the prospects of American capitalism, but the 29-page report also highlighted pitfalls like investment fees, and gimmicky corporate earnings. Though Buffett is the most followed investor on earth, his annual letter did not dwell much on new investments like Berkshire’s Apple and airlines bets, or deals in the marketplace.

Top Warren Buffett Stocks For 2018: lululemon athletica inc.(LULU)

Advisors’ Opinion:

  • [By Trey Thoelcke]

    And Lululemon Athletica Inc. (NASDAQ: LULU) is expected to release its most recent quarterly results on Thursday afternoon. The consensus forecast calls for $0.35 in EPS and revenue of $567.55 million. The stock ended the week at $60.21 a share. The consensus price target is $61.97, and the 52-week range is $47.26 to $79.41.

  • [By Lisa Levin]

    Shares of Lululemon Athletica inc. (NASDAQ: LULU) got a boost, shooting up 15 percent to $68.99 after the company reported stronger-than-expected earnings for its third quarter and announced a $100 million stock buyback plan.

  • [By Ben Levisohn]

    Lululemon Athletica (LULU) is scheduled to release its financial results on March 29 after the market close. And while half of the 36 analysts who Lululemon rate it a Buy or Outperform, that still means another half, well, don’t.

    Kevork Djansezian/Getty Images

    Count Macquarie’s Laurent Vasilescu and team among the latter. In a note today, they offered 10 reasons to be cautious about Lululemon, which they rate Underperform. Here are my excerpts:

    Same-store Sales: “We are concerned that store comps are in the low single digits, especially since the store fleet is very young,” Vasilescu warns. Margin Disclosure: “The level of disclosure around the gross margin continues to decrease,” Vasilescu claims. Margin Sapping Businesses: “Mens and ivivva are both growth drivers yet they are
    margin dilutive,” Vasilescu explains. Too many stores in the U.S.: “Prior management outlined many times the TAM of 300-350 stores in North America,”Vasilescu writes. “Lulu is reaching saturation.” U.S. Store Profitability: It’s much lower than in Canada, claims Vasilescu. Marketing: Not enough of it, especially compared to Nike (NKE), Adidas (ADDYY), and Under Armour (UAA), Vasilescu says. Not a tech company: On its third-quarter conference call, Lululemon said it was a quasi-tech company. It’s not, says Vasilescu. Competition: Denim. Beyonce. Amazon.com (AMZN). Ouch. High costs: “When comps turn negative we think this will pressure earnings, as we estimate high fixed SG&A costs,” write Vasilescu. Inventories: “Days in inventory remain elevated at 112 vs historical 3Q rate of 90,” warns Vasilescu.

    Shares of Lululemon Athletica have gained 0.6% to $64.06 at 2:32 p.m. today, while Nike has fallen 0.9% to $55.86, Adidas has dipped 0.1% to $96.27, Under Armour has risen 0.9% to $19.83, and Amazon.com has ticked up 0.1% to $846.38.

  • [By Chris Lange]

    Lululemon Athletica Inc. (NASDAQ: LULU) reported fiscal third-quarter financial results after markets closed on Wednesday. Overall these results demonstrated continued momentum for this yoga apparel producer in 2016 and beyond. With the stock up already over 10% year to date, this number is practically doubling after this report. Also it helped that guidance was not only in-line with estimates but these numbers are now expecting new highs.

  • [By Peter Graham]

    The Q3 2016 earnings report forlarge cap technical athletic apparel stock Lululemon Athletica inc (NASDAQ: LULU) isscheduled forafter the marketcloses onWednesday (December 7th) as the company gets hit by analyst downgrades:

Top Warren Buffett Stocks For 2018: Avangrid, Inc.(AGR)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Avangrid (AGR) was formed late last year by the merger of New England-based utility UIL Holdings (UIL) with the U.S. subsidiary of the Spanish utility giant Iberdrola SA (IBRDY).

  • [By WWW.THESTREET.COM]

    For his “Executive Decision” segment, Cramer sat down with James Torgerson, CEO of Avangrid (AGR) , the wind-power utility which just posted a three-cents-a-share earnings beat. Shares of Avangrid are up 10% for the year with a 4% dividend yield.

Top Warren Buffett Stocks For 2018: ABM Industries Incorporated(ABM)

Advisors’ Opinion:

  • [By Lisa Levin]

    ABM Industries, Inc. (NYSE: ABM) was down, falling around 16 percent to $36.98 after the company posted weak Q4 earnings and issued a downbeat full-year forecast.

Top Warren Buffett Stocks For 2018: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

share market holiday list

After Hurricane Harvey and Irma I have been hearing a lot of talk about what to short, what to go long, and other activities one should take as a result of these natural disasters.

While everyone should have a investment plan and strategy that should not be altered simply because some very strong wind and water blew over a particular part of the world, these kind of events do provide opportunities to dive into sectors to find value as valuations can be altered as a result of pessimism regarding certain industries or sectors.

One such group may the insurance and reinsurance names. Obviously, many of these companies are going to have a few bad quarters or a year as a result of increase catastrophe claims, but in the era of ETFs and indexing, many great insurers who are only lightly exposed or have superior qualitative aspects may be punished along with those directly exposed.

A Quick Look at Validus’ Past

share market holiday list: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

share market holiday list: Orocobre Limited (OROCF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

  • [By SEEKINGALPHA.COM]

    The question now is more about speed of EV implementation. On the supply side, it has been great to see LAC, Pilbara Minerals (OTCPK:PILBF) and Altura Mining (OTCPK:ALTAF) get funding, but the continued issues with Albemarle’s (NYSE:ALB) LaNegra II expansion and Orocobre (OTCPK:OROCF) ramping up to Phase 1 capacity of 17,500 tonnes/year of lithium carbonate are further evidence that lithium projects take time and have considerable execution risk.

share market holiday list: Transcontinental Realty Investors, Inc.(TCI)

Advisors’ Opinion:

  • [By Lee Jackson]

    Transcontinental Realty Investors Inc. (NYSE: TCI) saw itschief executive officerpurchasing stock last week. Daniel Moos bought a block of 285,000 shares at $10.60 apiece. The trade cost himright at $3 million.The company acquires, develops and owns residential and commercial real estate properties through acquisitions, leases and partnerships in the United States. Its shares closed Friday at $11.48.

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 0.23 percent. Meanwhile, top losers in the sector included Transcontinental Realty Investors Inc (NYSE: TCI), down 14 percent, and Citizens, Inc. (NYSE: CIA), down 5 percent.

share market holiday list: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

share market holiday list: Tronox Limited(TROX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tronox Ltd (NYSE: TROX) shares shot up 34 percent to $19.30. Tronox announced plans to acquire Cristal's TiO(2) business and also agreed to sell Alkali Business. Tronox posted a Q4 loss of $0.14 per share on revenue of $548 million.

  • [By Lisa Levin]

    Shares of Tronox Ltd (NYSE: TROX) were down 23 percent to $19.55. The FTC has challenged Tronox acquisition of Cristal’s titanium dioxide business. Tronox disclosed that it will fight FTC lawsuit seeking to block proposed acquisition of Saudi-owned Cristal.

share market holiday list: Manitex International Inc.(MNTX)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrial shares fell by 0.08 percent. Meanwhile, top losers in the sector included Accenture Plc (NYSE: ACN), down 4 percent, and Manitex International Inc (NASDAQ: MNTX), down 4 percent.

stock market symbols

Related AXON Oppenheimer Presents New Menu Of Top Picks Arena Upgraded, Analyst Sees 44% Upside
Related LEN 25 Stocks Moving In Tuesday's Pre-Market Session Homebuilders Under Pressure After Housing Market Index Hits 8-Month Low

Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity.

Here's a recap of the options alerts from Friday, September 18, 2017. All time stamps are in Eastern Time.

3:43:30 pm: AXON Axovant Oct 20 $40 Calls Above Ask!: 5998 @ $7.22 vs 5220 OI; Ref=$22.77

2:57:30 pm: LEN Lennar Oct 20 $52.5 Calls at the Bid: 1732 @ $0.99 vs 427 OI; Ref=$51.76

2:33:41 pm: MAT Mattel Oct 20 $15 Puts Sweep (2) at the Ask: 7500 @ $0.776 vs 7020 OI; Ref=$14.8

1:59:08 pm: NG NovaGold Oct 20 $5 Puts Sweep (10) at the Bid: 872 @ $0.902 vs 20 OI; Ref=$4.12

1:52:02 pm: BIG Big Lots Oct 20 $47.5 Puts Sweep (29) at the Bid: 1919 @ $0.7 vs 465 OI; Ref=$49.84

stock market symbols: Fiesta Restaurant Group, Inc.(FRGI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows El Pollo LoCo Holdings stabilizing over thepast two yearswhile potentialpeers like large cap Chipotle Mexican Grill, Inc (NYSE: CMG) andsmall capsFiesta Restaurant Group Inc (NASDAQ: FRGI) and Chuy’s Holdings Inc (NASDAQ: CHUY)have performed better in the past and appear to be in downtrends for the past 1 1/2 years:

  • [By Peter Graham]

    A long term performance chart shows Del Taco Restaurants now outperforming Mexican restaurant stock peers such as mid cap Chipotle Mexican Grill, Inc (NYSE: CMG) and small caps El Pollo LoCo Holdings Inc (NASDAQ: LOCO), Fiesta Restaurant Group Inc (NASDAQ: FRGI) and Chuy’s Holdings Inc (NASDAQ: CHUY) have mostly been drifting lower lately:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By Peter Graham]

    A long term performance chart shows Chipotle Mexican Grills shares back to breakeven while of the small caps peers, El Pollo LoCo Holdings Inc (NASDAQ: LOCO) has had the worst performance, Fiesta Restaurant Group Inc (NASDAQ: FRGI) is off its 2015s peak and Chuy’s Holdings Inc (NASDAQ: CHUY) has been a mixed performer:

  • [By Lisa Levin]

    Fiesta Restaurant Group Inc (NASDAQ: FRGI) shares dropped 24 percent to $19.83. Fiesta Restaurant posted in-line Q4 earnings, but sales missed estimates. The company also disclosed that it has suspended its sale exploration process and appointed a new CEO. Raymond James downgraded Fiesta Restaurant from Outperform to Market Perform.

stock market symbols: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

stock market symbols: Omega Healthcare Investors, Inc.(OHI)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Or, consider Omega Healthcare Investors (OHI). The Maryland-based company invests heavily in hospital properties and health care facilities, with a special emphasis on nursing facilities.

  • [By Paul Ausick]

    Omega Healthcare Investors Inc. (NYSE: OHI) dropped about 2.6% Monday to post a new 52-week low of $26.43 after closing at $27.14 on Friday. The 52-week high is $35.14. Volume was around 5.3 million, more than double the daily average of around 2.3 million. The healthcare REIT had now specific news.

stock market symbols: Medtronic plc(MDT)

Advisors’ Opinion:

  • [By Nelson Hem]

    Lawrence C. Strauss’s “Medtronic: Healthy and Getting Healthier” points out that some investors are skeptical about the prospects for this Dublin-based medical device maker. But are those investors underestimating the strength of Medtronic PLC (NYSE: MDT)? Find out why Barron’s believes the company’s shares could climb up to 15 percent over the next 12 months.

  • [By Todd Campbell]

    At Medtronic (NYSE:MDT), one of the country’s largest medical-device companies, these sensors are even attached to an insulin pump patients wear that canautomatically administer insulin as it’s needed.

  • [By Matthew Briar]

    What do you get when you combine a medical device company like Medtronic plc (NYSE:MDT) and a mobile communication device like the iPhone from Apple Inc. (NASDAQ:AAPL)? You get a CardioComm Solutions Inc. (OTCMKTS:EKGGF, CVE:EKG), which can turn your smartphone into a high-powered, high-functioning heart-monitoring piece of hardware as potent as anything you’d have access to in the hospital.

    Yes, there’s a market for the melding of what Apple and Medtronic — and several other players — do. The healthcare wearable market was worth $5.1 billion in 2015, and now that such technologies are being accepted, its revenues could reach $19 billion by 2020. Meanwhile, the heart-monitoring space happens to be a market worth more than $20 billion per year, and some say it will be worth $26.7 billion by 2020. CardioComm Solutions is nestled nicely between the two of them.

    CardioComm Solutions is the name behind a brand of wellness products sold under the HeartCheck monikor. Those devices are small, handheld portable ECG (electrocardiogram) readers that put the power of a doctor’s or hospital’s heart-monitoring hardware in the hands of individuals who can use them just as effectively.

    Its flagship products are the HeartCheck ECG Pen, for consumers (available without a prescription), and the HeartCheck ECG monitoring device (available only by prescription) that’s a higher-level technology. More are on the way too. The ECG ‘Card’ is a credit-card sized device that syncs up with — and is powered by — a smartphone in close proximity. Also on the way is the HeartCheck band, which is worn on the wrist. It does a lot that the Fitbit bands do, with the added benefit of being able to produce clinical-grade ECG readouts viewable not just by the user, but by a doctor, clinic, or call center if that user chooses to deliver them remotely using the company’s platform.

    Bolstering the value proposition is the fact that all of its wares are — or will be

  • [By Ben Levisohn]

    Cardinal Health (CAH) tumbled to the bottom of the S&P 500 today after agreeing to buy Medtronic’s (MDT) medical supplies business for $6.1 billion and offering disappointing guidance.

  • [By Paul Ausick]

    Medtronic plc (NYSE: MDT) dropped about 2.6% Tuesday to post a new 52-week low of $69.35 after closing Friday at $71.23. The 52-week high is $89.27. Volume of around 8.6 million was about 20% more than the daily average of around 6.2 million shares traded. The company’s stock was downgraded this morning at Morgan Stanley.

stock market symbols: Alliance Data Systems Corporation(ADS)

Advisors’ Opinion:

  • [By Teresa Rivas]

    Alliance Data Systems (ADS) was the worst performer in the S&P 500 Tuesday.

    Getty Images

    ADS shares fell $9.32, or 3.8%, to $238.32, compared to the S&P 500, which fell 3.38 points, or 0.14%, to 2353.78.

    The shares were hurt by a bearish note from Oppenheimer: Analysts Ben Chittenden and Dominick Gabriele initiated coverage of the stock with an Underperform rating and a $185 price target.

    Details from the note:

    Long investors seem generally to believe that the profitability of ADS’s capital-light/data-driven/tech-based businesses (Epsilon/LoyaltyOne) will turn relatively soon and that EPS will be driven by more than just the card business. The logical conclusion is the multiple should be FinTech-based. We think it’s just as easy to make the case that, while ADS had a first-mover advantage on data-driven, SKU-level analytics, competitive advantage is diminishing and the profitability of these businesses will likely take longer to turn (and likely not return to historical levels). Thus, earnings will continue to be driven by the balance sheet-intensive card business (our ’18E EPS is 6% below consensus) and should be valued as such, we think.

    Advanced Micro Devices(AMD) was the worst performer in the S&P 500 yesterday.

     

  • [By Ben Levisohn]

    Alliance Data Systems (ADS) soared to the top of the S&P 500 today after beating the Street’s earnings and revenue expectations.

    Getty Images

    Alliance Data Systemsgained 8.3% to $260.62, while the S&P 500 rose 0.8% to 2,355.84.

    Evercore ISI’s David Togut and team argue that Alliance Data Systems is “checking the right boxes.” They explain:

    ADS’ 1Q/17 earnings reinforced our conviction that net charge offs will stabilize at the end of this year, driving accelerating earnings growth in 2018. Card Services surpassed our revenue and EBITDA forecasts fueled by an 80 basis point increase in gross card yield thanks to rising interest rates. Epsilon’s revenue growth accelerated to 7% from a 1% decline in 4Q/16 driven by double digit growth in Automotive, Agency and digital CRM plus an easy comparison. LoyaltyOne revenue and EBITDA fell below our estimates given soft results from AIR MILES, which is adjusting its value proposition after the Ontario Legislature last December eliminated the expiration date on AIR MILES. Overall, ADS remains on track to generate double-digit adjusted EBITDA and EPS gains in 2017, and in 2018 to accelerate EPS growth to the mid-teens given slowing headwinds from delinquencies plus operating leverage from stabilizing net charge-off rates.

    Alliance Data Systems’ market capitalization rose to $14.6 billion today from $13.5 billion yesterday.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Alliance Data Systems Corp. (NYSE: ADS) which traded down 3.9% at $238.00. The stocks 52-week range is $185.02 to $254.94. Volume was 1.6 million versus the daily average of 577,000 shares.

stock market symbols: Insulet Corporation(PODD)

Advisors’ Opinion:

  • [By Brian Feroldi]

    Shares of Insulet Corporation(NASDAQ:PODD), a medical device company primarily focused on diabetes,rose by as much as 11% in afternoon trading on Friday.

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better:

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation peaking in 2014 before falling below the more steady performance of diabetes or insulin stocks like large cap Novo Nordisk A/S (NYSE: NVO) and small cap Insulet Corporation (NASDAQ: PODD):

really good stocks to invest in

The coffee trade is setting up for another bounce.   When we pocketed a 30% gain on the iPath Bloomberg Coffee Subindex Total Return Fund (JO) last month, I wrote that we'd look to get back into the position when coffee relieves its overbought position and comes back down toward a support level.   I didn't think it would happen so soon. But here we are…   Let's start with an updated chart of the price of coffee…  
  Since early November, the price of coffee has fallen from $1.74 per pound to $1.39. That's a 20% drop in one month.  

really good stocks to invest in: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

really good stocks to invest in: Black Box Corporation(BBOX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Black Box Corporation (NASDAQ: BBOX) is expected to post its quarterly earnings at $0.26 per share on revenue of $218.41 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

really good stocks to invest in: The Michaels Companies, Inc.(MIK)

Advisors’ Opinion:

  • [By Jim Cramer]

    The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Specialty Retail industry average. The net income increased by 20.0% when compared to the same quarter one year prior, going from $64.00 million to $76.80 million.

     

  • [By JPMorgan]

    MIK’s results over the past year point to the company’s success in improving merchandising, marketing, and in-store execution plus the benefits of having a functioning e-commerce website. We believe part of the challenge for the bears is both a lack of appreciation for the category as well as missing the historical context of how leadership has evolved. Indeed, the difference in focus on "the front end" under CEO Chuck Rubin (who arrived in 2013) vs. a more process-oriented and margin-focused CEO prior to his arrival left a lot of impactful, low hanging fruit opportunities. Finally, while we acknowledge that longer term the sustainable comp is lower than the recent ~4% underlying trend, we point to the low volatility of sales, high cash generative nature of the business, barriers to entry (e.g., high SKU density, low inventory turns, lack of brands), and MIK’s market leadership as reasons why the multiple has the potential to expand over time (a la AZO). Balance sheet de-levering should also make the PE look increasingly cheap over time and transfer cash/value to equity holders. 

  • [By WWW.THESTREET.COM]

    Earnings of note in the coming week include Analogic (ALOG) and Ascena Retail (ASNA) on Monday; Bojangles (BOJA) , H&R Block (HRB) , and Dick’s Sporting Goods (DKS) , Michaels (MIK) , and Urban Outfitters (URBN) on Tuesday; Ciena (CIEN) , Bankrate (RATE) , Express (EXPR) , Vera Bradley (VRA) , and Bob Evans Farms (BOBE) on Wednesday; El Pollo Loco (LOCO) , Hugo Boss (BOSSY) , Party City (PRTY) , Signet Jewelers (SIG) , and Verifone Systems (PAY) on Thursday; and Kirkland’s (KIRK) , and Vail Resorts (MTN) on Friday.

  • [By Laurie Kulikowski]

    We rate MICHAELS COS INC as a Sell with a ratings score of D+. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. Among the areas we feel are negative, one of the most important has been weak operating cash flow. 

  • [By Jim Cramer]

    42.37% is the gross profit margin for MICHAELS COS INC which we consider to be strong. Regardless of MIK’s high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 6.57% trails the industry average.

    MICHAELS COS INC has improved earnings per share by 19.4% in the most recent quarter compared to the same quarter a year ago. This year, the market expects an improvement in earnings ($1.70 versus $1.04).

     

really good stocks to invest in: Atlas Air Worldwide Holdings(AAWW)

Advisors’ Opinion:

  • [By Paul Ausick]

    Amazon leased 40 planes from Air Transport Services Group Inc. (NASDAQ: ATSG) and Atlas Air Worldwide Holdings Inc. (NASDAQ: AAWW). Each carrier is supplying 20 Boeing jets to Prime Air.

really good stocks to invest in: Navigant Consulting, Inc.(NCI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Navigant Consulting, Inc. (NYSE: NCI) were down 14 percent to $17.02 after the company posted downbeat quarterly results.

    Hertz Global Holdings, Inc (NYSE: HTZ) was down, falling around 18 percent to $14.24. Barclays downgraded Hertz from Equal-Weight to Underweight.

really good stocks to invest in: Chimerix, Inc.(CMRX)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    The lead product candidate from Chimerix (CMRX) is brincidofovir (CMX001), a nucleotide analog.

    The drug is in Phase III clinical trials for the prevention of cytomegalovirus (CMV) in allogeneic hematopoietic cell transplant (HCT) recipients and in kidney transplant recipients, as well as to treat adenovirus infection in allogeneic HCT patients.

investment funds

Monsanto Company (NYSE:MON) is a $52.3 billion in market value constituent of the Chemicals GICS industry group where the stock’s current Portfolio Grader score places it 5 among the 96 companies in this industry group, positioning it among the leaders. MON is ranked in the top decile of the sector with a ranking of 10 among the 266 companies in the sector and number 244 in the 5000 company Portfolio Grader company universe.

MON has a current recommendation of Strong Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

The Materials sector is ranked number 8 among the 12 sectors in the Portfolio Grader universe putting it in the third quartile of all the GICS sectors. The Chemicals industry group is ranked 40 among the 69 industry groups within the GICS sectors, placing it below-average in terms of the Navellier scoring system.

investment funds: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

investment funds: Pacific Mercantile Bancorp(PMBC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Pacific Mercantile Bancorp (NASDAQ: PMBC) were down 24 percent to $5.78. Pacific Mercantile Bancorp reported a Q3 loss of $30.5 million on revenue of $10.2 million for its third quarter.

investment funds: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion. CST Brands shares declined 1.20 percent to close at $36.21 on Thursday.

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

    American Axle & Manufact. Holdings, Inc. (NYSE: AXL) is expected to report its quarterly earnings at $0.71 per share on revenue of $998.76 million.

investment funds: International Speedway Corporation(ISCA)

Advisors’ Opinion:

  • [By Monica Gerson]

    International Speedway Corp (NASDAQ: ISCA) is estimated to report its quarterly earnings at $0.41 per share on revenue of $146.09 million.

    Mitcham Industries, Inc. (NASDAQ: MIND) is projected to post a quarterly loss at $0.36 per share on revenue of $10.99 million.

  • [By Monica Gerson]

    International Speedway Corp (NASDAQ: ISCA) is projected to report its quarterly earnings at $0.41 per share on revenue of $146.09 million. International Speedway shares declined 1.65 percent to close at $36.26 yesterday.

investment funds: National Oilwell Varco, Inc.(NOV)

Advisors’ Opinion:

  • [By Tony Daltorio]

    But the best investment in this sector, according to Moors, is National Oilwell Varco Inc. (NYSE: NOV).

    He calls it the “one company that stands to benefit most directly from what is happening in the equipment sector.”

  • [By Lauren Pollock]

    Among the companies with shares expected to actively trade in Tuesday’s session are Applied Materials Inc.(AMAT), Red Hat Inc.(RHT) and National Oilwell Varco Inc.(NOV)

  • [By Jim Robertson]

    On Tuesday, our Elite Opportunity Pronewsletter suggestedgoing long on large cap oilfield equipment manufacturer and technology stock National-Oilwell Varco, Inc (NYSE: NOV):

Top 10 Low Price Stocks To Own Right Now

Wal-Mart (NYSE:WMT) has made a lot of efforts in pricing its goods attractively over the past months. This allowed for strong traffic growth, which resulted in positive comps for the company. Subsequently, Wal-Mart’s shares have been performing much better than those of its peers, which are reporting worse comp sales. Due to Wal-Mart’s power when it comes to discussing prices with its suppliers, the company is able to price its goods attractively whilst generating strong margins, which, in turn, means that the earnings power of Wal-Mart remains high (despite the low prices Wal-Mart offers its goods at), which makes Wal-Mart a compelling retail investment.

Top 10 Low Price Stocks To Own Right Now: United Technologies Corporation(UTX)

Advisors’ Opinion:

  • [By Paul Ausick]

    United Technologies Inc. (NYSE: UTX) traded up 1.35% at $118.45. The stock’s 52-week range is $96.89 to $119.258, and the high was posted this afternoon. Volume was about a third higher than the daily average of around 3 million. The industrial giant reported results this morning that were better than estimates on both profits and revenues.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded down 0.78% at $121.17. The stock’s 52-week range is $96.89 to $122.85. Volume was about 15% below the daily average of around 2.9 million shares. The company had no specific news Monday.

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage gain ahead of the close Monday was United Technologies Corp. (NYSE: UTX) traded up 2.08% at $110.78. The stock’s 52-week range is $83.39 to $111.69. Volume was about 10% below the daily average of around 3.6 million shares. The company’s stock was lifted from Neutral to Outperform by Credit Suisse analysts on Monday.

  • [By Shanthi Rexaline]

    Here is the list of the Dow components, which are scheduled to report this week:

    1. 3M Co
    Company: 3M Co (NYSE: MMM). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $2.54 versus $2.08. Revenue Estimate: $7.86 billion versus $7.66 billion. Stock Gain/Loss (year to date): 18.12 percent.
    2. Caterpillar
    Company: Caterpillar Inc. (NYSE: CAT). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.25 versus $1.09. Revenue Estimate: $10.93 billion versus $10.94 billion. Stock Gain/Loss (year to date): 16.10 percent.
    3. McDonald’s
    Company: McDonald’s Corporation (NYSE: MCD). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.62 versus $1.45. Revenue Estimate: $5.96 billion versus $6.26 billion. Stock Gain/Loss (year to date): 25.35 percent.
    4. United Technologies
    Company: United Technologies Corporation (NYSE: UTX) Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.78 versus $1.82. Revenue Estimate: $15.24 billion versus $14.87 billion. Stock Gain/Loss (year to date): 12.47 percent.

    See also: 3 Reasons Alcoa Is No Longer The Curtain-Raising Event Of Earnings Season

Top 10 Low Price Stocks To Own Right Now: iShares Global Infrastructure (IGF)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    It also helps to find funds that can make any wait bearable and even profitable. Several ETFs stand out for their relatively low cost, modest risk and reasonable yields. They include the Guggenheim S&P High Income Infrastructure ETF (GHII) , iShares S&P Global Infrastructure Index Fund (IGF) and FlexShares STOXX Global Broad Infrastructure Index Fund (NFRA) .

  • [By Wayne Duggan]

    Investors who are looking to invest in the companies that will likely be playing a central role in America’s infrastructure investment may want to consider the iShares S&P Global Infrastructure Index (NYSE: IGF).

Top 10 Low Price Stocks To Own Right Now: RadiSys Corporation(RSYS)

Advisors’ Opinion:

  • [By Lisa Levin]

    RadiSys Corporation (NASDAQ: RSYS) was down, falling around 18 percent to $2.97 after the company lowered its sales forecast for the second quarter. The company now expects Q2 sales of $35 million, versus earlier outlook of $41 million to $47 million.

  • [By Lisa Levin]

    RadiSys Corporation (NASDAQ: RSYS) was down, falling around 18 percent to $2.95 after the company lowered its sales forecast for the second quarter. The company now expects Q2 sales of $35 million, versus earlier outlook of $41 million to $47 million.

Top 10 Low Price Stocks To Own Right Now: Alon USA Partners, LP(ALDW)

Advisors’ Opinion:

  • [By Tom Dorsey]

    Over a several day period, I submitted questions and Mr. Eisman, President, Chief Executive Officer and Director of Alon USA Energy Inc. (ALJ) and the parent company of Alon USA Partners LP Inc. (ALDW) responded. He provided some key insights to some challenges the company faces, where the company is going, and the opportunities available in the future. This insight should provide investors with additional information to understand the value of the company and the opportunity as an investor in the company.

Top 10 Low Price Stocks To Own Right Now: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

Top 10 Low Price Stocks To Own Right Now: Federated Investors, Inc.(FII)

Advisors’ Opinion:

  • [By Gregg Greenberg]

     Stocks of Federated Investors (FII) fell approximately 9% in 2015, yet Oja expects a big turnaround in 2016, once again due to the prospect of higher rates ahead. 

     

    "The money market fund business, which is unprofitable now, should become more profitable as rates rise because Federated has to reimburse for the servicing fees for these funds," said Oja, who also admires the fund company’s 3.5% dividend yield. 

     

    Oja added that Federated also has a "good core business of equity and fixed-income asset management." 

Top 10 Low Price Stocks To Own Right Now: Novo Nordisk A/S(NVO)

Advisors’ Opinion:

  • [By Keith Speights]

    Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY) fit that description well. Each of these companies markets obesity drugs, but each also sells a broad array of other products with multiple pipeline candidates potentially on the way. Here’s why Eisai, Novo Nordisk, and Roche rank as the three best obesity-drug stocks to buy in 2017.

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better:

  • [By Paul Ausick]

    Novo Nordisk A/S (NYSE: NVO) dropped about 1.5% on Friday to post a new 52-week low of $32.35 after closing at $32.84 on Thursday. The stock’s 52-week high is $59.00. Volume of about 3.4 million was close to the daily average of around 3.9 million shares. The drug maker had no specific news.

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.

    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.

    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

  • [By Brian Orelli]

    Global Blood Therapeutics (NASDAQ:GBT) is up 20% at 3:42 p.m. EST after Reuters reported that Novo Nordisk (NYSE:NVO) has approached the biotech about a potential acquisition.

Top 10 Low Price Stocks To Own Right Now: Curis, Inc.(CRIS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Paul Ausick]

    Curis Inc. (NASDAQ: CRIS) matched a 52-week low of $0.88 set Friday. The 52-week high is $3.48. Volume was about 4 million, four times the daily average of around 1 million. The drugmaker had no specific news Monday.

Top 10 Low Price Stocks To Own Right Now: Molson Coors Brewing Company(TAP)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the past, Cramer has been a fan of both Constellation as well as Molson Coors (TAP) , which was able to snap up all the Miller and Coors brands last year for $12 billion. That deal is expected to boost Molson’s earnings by 25% this year.

  • [By Seth McNew]

    It isn’t the only beer company facing hardships now, and in fact, it’s still growing faster than its largest competitors — Sam Adams parent Boston Beer (NYSE:SAM) and Molson Coors Brewing (NYSE:TAP). Boston Beer’s total sales fell 5.4% in 2016, year over year, and Molson Coors’ sales were down 2.3%.

  • [By Jayson Derrick]

    The Canadian beer market, much like the American beer market, is seeing a growth in craft products at the expense of established players. And one of the biggest established beer makers in Canada is Molson Coors Brewing Co (NYSE: TAP), Bereneberg’s Javier Gonzalez Lastra and Matt Reid commented in an initiation note.

  • [By Mark Fritz]

    Price Target: 116 euros.

    Molson Coors Brewing Co (NYSE: TAP): Sell.
    Price Target: $78.

    Boston Beer Company Inc (NYSE: SAM): Sell.

    Price Target: $124.

Top 10 Low Price Stocks To Own Right Now: DBV Technologies S.A.(DBVT)

Advisors’ Opinion:

  • [By Paul Ausick]

    DBV Technologies SA (NASDAQ: DBVT) dropped about 53.5% Monday to post a new 52-week low of $22.33 after closing at $48.07 on Friday. The stock’s 52-week high is $50.57. Volume of around 12 million was about 60 times the daily average. The French drug maker’s peanut allergy treatment failed a phase 3 study.

  • [By Lisa Levin]

    DBV Technologies SA – ADR (NASDAQ: DBVT) shares dropped 46 percent to $26.11 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.

  • [By Monica Gerson]

    DBV Technologies SA ADR (NASDAQ: DBVT) is expected to post a quarterly loss at $0.60 per share.

    Northern Technologies International Corp (NASDAQ: NTIC) is projected to post its quarterly earnings.

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

Top 10 Stocks For 2018

Related GOOG This Biometric ID System Allows You To Buy Weed, Booze And Other Controlled Products From A Vending Machine Goldman Compares 'FAAMG' Stocks To High-Flyers Of The Dot-Com Bubble
Related GOOGL Here's Why Tech Stocks Fell Today Ever Had An App Idea? This Contest Can Make It Come To Life – And Even Bring In Some Cash Stocks End Mixed As 5 Names Spearhead The Tech Dive (Investor’s Business Daily)

Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) announced last week that Google chrome will automatically block all advertisements on sites that feature a certain level unacceptable ad formats identified by the Coalition for Better Ads, reported the Wall Street Journal.

Top 10 Stocks For 2018: GenMark Diagnostics, Inc.(GNMK)

Advisors’ Opinion:

  • [By Lisa Levin]

    GenMark Diagnostics, Inc (NASDAQ: GNMK) shares shot up 20 percent to $10.54. Cowen & Co. upgraded GenMark Diagnostics from Market Perform to Outperform.

Top 10 Stocks For 2018: Eagle Materials Inc(EXP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.10 percent. Meanwhile, top losers in the sector included Mechel PAO (ADR) (NYSE: MTL), down 8 percent, and Eagle Materials, Inc. (NYSE: EXP), down 6 percent.

  • [By David Sterman]

    Of course, in many cyclical industries, it’s impossible to maintain very strong growth rates when the economy slumps. And that was a lesson learned by Eagle Materials (NYSE: EXP(link is external)), a maker of drywall, cement and other materials used in homebuilding. Eagle experienced solid growth a decade ago, but when the housing market tanked, so did Eagle’s revenue base. Sales fell by half from fiscal 2007 through fiscal 2011 (to around $460 million).

    Yet even before the pace of home construction returns to normal levels, Eagle is again experiencing solid growth: Sales are now growing at a 30% pace and are expected to surpass $1.1 billion in the current fiscal year, which began this month. That’s 25% higher than the peak in fiscal 2007, and it’s setting the stage for solid profit growth: Earnings per share (EPS) are growing at a 50% pace these days, a pace which could be sustained for an extended period if the housing market finally starts to grow at a solid clip. 

  • [By Maxx Chatsko]

    Shares of construction materials leader Eagle Materials (NYSE:EXP) set new all-time highs earlier this year, although the stock’s recent surge was catalyzed by the announcement of fiscal second-quarter 2017 results in late October. At the time, the company set record revenues and more than doubled earnings per share from the prior-year period. That was followed by a new high watermark for quarterly sales in the fiscal third quarter of 2017, which ended in December, marking the third consecutive quarter in which record revenue was established.

Top 10 Stocks For 2018: Cal-Maine Foods, Inc.(CALM)

Advisors’ Opinion:

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian said that Cal-Maine Foods Inc (NASDAQ: CALM) had unusually high options volume on Friday. Traders were buying the May 45 calls and Jon Najarian decided to follow the trade. He is planning to hold the position for 1 to 2 months.

  • [By Ben Levisohn]

    Cal-Maine Foods (CALM) has tumbled 6.3% to $35.00 after missing earnings forecasts.

    EXACT Sciences (EXAS) after its Cologard test was‘considered medically necessary every 3 years’ byAetna (AET). Aetna is unchanged at$126.77.

  • [By Lisa Levin]

    Cal-Maine Foods Inc (NASDAQ: CALM) posted in-line loss for its second quarter, but sales missed expectations.

    Cal-Maine Foods reported a Q2 loss of $0.48 per share on revenue of $253.5 million. Analysts were expecting a loss of $0.48 per share on revenue of $262.8 million.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Rite Aid Corporation (NYSE: RAD) to report quarterly earnings at $0.04 per share on revenue of $8.23 billion before the opening bell. Rite Aid shares gained 0.83 percent to $8.54 in after-hours trading.
    Micron Technology, Inc. (NASDAQ: MU) reported better-than-expected profit for its first quarter and issued a strong forecast for the current quarter. Micron shares climbed 9.91 percent to $22.62 in the after-hours trading session.
    Analysts expect Cal-Maine Foods Inc (NASDAQ: CALM) to post quarterly earnings at $0.48 per share on revenue of $262.83 million after the closing bell. Cal-Maine shares rose 0.12 percent to $42.75 in after-hours trading.
    Red Hat Inc (NYSE: RHT) reported upbeat earnings for its third quarter, but sales missed expectations. The company also announced that its CFO Frank Calderoni is stepping down. Red Hat shares tumbled 10.15 percent to $71.69 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Tyler Crowe, Jordan Wathen, and Beth McKenna]

    So we asked three of our contributors to highlight a stock they see as a real underdog in the market today and why investors should be watching this stock. Here’s a quick look into why they picked banker Wells Fargo (NYSE:WFC), railcar manufacturer Greenbrier Companies (NYSE:GBX) , and egg wholesaler Cal-Maine Foods (NASDAQ:CALM)

Top 10 Stocks For 2018: Renewable Energy Group, Inc.(REGI)

Advisors’ Opinion:

  • [By Manikandan Raman]

    There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).

Top 10 Stocks For 2018: Unilever NV(UN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, industrial shares fell by 0.04 percent. Meanwhile, top losers in the sector included Unilever N.V. (ADR) (NYSE: UN), down 8 percent, and Magal Security Systems Ltd. (USA) (NASDAQ: MAGS), down 6 percent.

  • [By Teresa Rivas]

    Earlier this year, Unilever (UN) recently declined Kraft Heinz (KHC) merger bid. That means that if the company still wants to do a deal, Mondelez International (MDLZ) and PepsiCo (PEP) are the next logical partners, writes Susquehannas Pablo Zuanic.

    Getty Images

    Zuanic upgraded Pepsi from Neutral to Positive today and raised his price target from $118 to $132. He writes that a Pepsi deal would have more strategic merits, hence his upgrade (as he emphasizes that not much has changed in terms of fundamentals for the firm).

    More detail from his note:

    With investors apparently seeing MDLZ as the next likely KHC target, and Coca-Cola (KO) the next Anheuser-Busch (BUD) target, PEP shares have lost visibility and now trade at a 25% discount to KO on apples-to-apples comps. We see value here, on franchise strength, efforts to align the F&B portfolio with consumer health trends, and the growing optionality value of a joint KHC/BUD bid for PEP. We argue that, together, the Kendall Jenner commercial, the Aspartame to-be-or-not-to-be zigzagging, the new, new, new alt low-cal cola (Pepsi Zero sugar), the ongoing underperformance in U.S. CSDs (25% only of the company), the lack of scale in non-CSD NARTDs vs. KO (other than Gatorade), and now talk of PEP buying Brazilian dairy company Vigor S.A. (a JBS subsidiary that would better fit KHC or ULVR), all paint a picture of a company still struggling to set a new direction (with all due respect). In this regard, we think PEP may be more vulnerable than MDLZ to a KHC bid (jointly done with BUD). We also see greater strategic fit for KHC with PEP Food/Snacks (than with MDLZ), and argue that PEP Beverages fits BUD better than KO, as the PEP bottling operations in key regions (including NA) remain in the hands of PEP (KO, on the other hand will be fully refranchised by end of 2017). So we are upgrading PEP to Positive with a $132 price target by December 17. Yes, the Unilever rebuff

Top 10 Stocks For 2018: BioPharmX Corporation(BPMX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of BioPharmX Corp (NYSE: BPMX) were down 31 percent to $1.02 after the company announced the pricing of 3.6 million share common stock.

    Puma Biotechnology Inc (NYSE: PBYI) was down, falling around 22 percent to $27.53 after the company issued an update to the timeline for the filing of a new drug application. Puma Biotechnology will submit the NDA for neratinib in mid-2016. According to a press release, the decision was based on the company’s recent meetings with the U.S. Food and Drug Administration.

Top 10 Stocks For 2018: Brady Corporation(BRC)

Advisors’ Opinion:

  • [By Michael Flannelly]

    Before the opening bell on Thursday, identification solutions provider Brady Corp (BRC) posted a loss in the fourth quarter, despite a rise in revenues, as it was negatively impacted by a number of charges. However, excluding these charges, the company was able to top Wall Street analysts’ earnings and sales estimates. Nonetheless, BRC shares are plummeting in Thursday’s trading.

    The Milwaukee, Wisconsin-based company posted a loss from continuing operations of $176.2 million, or $3.41 per share, in the fourth quarter, versus last year’s fourth quarter earnings from continuing operations of $20.9 million, or 40 cents per share. Furthermore, Brady posted a net loss of $177.2 million, or $3.43 per share, compared to net earnings of $11.6 million, or 22 cents per share, in the same period a year ago.

    The fourth quarter loss includes non-cash impairment charges of $204.4 million, $15.6 million in restructuring charges, and $4 million in acquisition-related charges. Excluding these charges, Brady Corp said earnings would have been 53 cents per share in the quarter. According to analysts polled by Thomson Reuters, the company was expected to earn an adjusted 51 cents per share in the fourth quarter.

    The company’s fourth quarter sales came in at $309.1 million, up 15% from $269.1 million in sales posted last year. On average, analysts were expecting the company to see $307.13 million in revenues for the quarter.

    Looking ahead, Brady Corp. sees fiscal 2014 earnings coming in between $1.80 and $2.00 per share, below the analysts’ view of $2.30 per share.

    Brady Corp shares were down $1.71, or 5.25%, during early morning trading on Thursday. The stock is up 7.93% year-to-date.

  • [By Mike Deane]

    For the 28th year in a row, Brady Corp (BRC) has increased its dividend payout to investors.

    The Milwaukee, WI-based company increased its quarterly dividend to 19.5 cents from 19 cents, an increase of 2.6%. The annual dividend now stands at 78 cents. The quarterly dividend will be paid on October 31st, 2013 to all shareholders of record on October 10, 2013.

    BRC shares were down 40 cents, or 1.23%, by market close on Wednesday. YTD, the company’s stock is down over 4%.

  • [By Shauna O’Brien]

    Robert Baird announced on Friday that it has cut its rating on Brady Corp (BRC).

    The firm has downgraded BRC from “Outperform” to “Neutral,” and has given the company a $33 price target. This price target suggests a 8% upside from the stock’s current price of $30.52.

    Analysts see the company’s WPS segment growing faster than expected.

    Brady shares were mostly flat during pre-market trading Friday. The stock is down 9% YTD.

Top 10 Stocks For 2018: Hooker Furniture Corporation(HOFT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Hooker Furniture Corporation (NASDAQ: HOFT) shares were also up, gaining 27 percent to $39.80 after the company reported strong results for its fourth quarter.

  • [By Monica Gerson]

    Hooker Furniture Corporation (NASDAQ: HOFT) is estimated to report its quarterly earnings at $0.40 per share on revenue of $62.20 million.

    SeaChange International (NASDAQ: SEAC) is projected to post its quarterly earnings at $0.01 per share on revenue of $30.49 million.

Top 10 Stocks For 2018: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

  • [By Monica Gerson]

    Analysts are expecting Exelon Corporation (NYSE: EXC) to have earned $0.68 per share on revenue of $7.52 billion in the latest quarter. Exelon shares rose 0.34 percent to close at $35.38 on Thursday.

  • [By Horizon Investments]

    For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 – the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company’s management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

  • [By Lisa Levin]

    Utilities shares climbed by 0.64 percent in trading on Friday. Meanwhile, top gainers in the sector included Exelon Corporation (NYSE: EXC), and FirstEnergy Corp. (NYSE: FE).

Top 10 Stocks For 2018: Pebblebrook Hotel Trust(PEB)

Advisors’ Opinion:

  • [By Marshall Hargrave]

    The other key benefit for Strategic is that it enjoys industry-leading earnings before interest, taxes, depreciation and amortization (EBITDA) per available room. For 2012, Strategic generated $81 per room of EBITDA. Compare this to top comps LaSalle Hotel (NYSE: LHO) at $74 per room and Pebblebrook Hotel Trust (NYSE: PEB) at $71. The reason for this is that Strategic is much less reliant than its peers on rooms, with much greater exposure to food and beverages. Strategic earns 53% of its revenue from rooms, while its peers get around 66% of revenues from rooms.